Home › Funds › Wells Fargo & Co › ALGS
Wells Fargo & Co position in ALGS
ALIGOS THERAPEUTICS INC · Health Care
Latest position (Q2 2026)100 sh
Reported value held$577
Portfolio Weight0.00%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 8.56K | $101.00K | New |
| Q1 2022 | 1.05K | $2.00K | Reduce |
| Q2 2022 | 125 | $0 | Reduce |
| Q3 2022 | 169 | $0 | Add |
| Q4 2022 | 173 | $165 | Add |
| Q1 2023 | 176 | $154 | Add |
| Q2 2023 | 198 | $192 | Add |
| Q3 2023 | 195 | $146 | Reduce |
| Q4 2023 | 293 | $195 | Add |
| Q1 2024 | 298 | $292 | Add |
| Q4 2024 | 21.80K | $868.51K | New |
| Q1 2025 | 23.03K | $190.00K | Add |
| Q2 2025 | 13.77K | $99.28K | Reduce |
| Q3 2025 | 3.17K | $31.07K | Reduce |
| Q4 2025 | 1.50K | $13.98K | Reduce |
| Q1 2026 | 700 | $5.20K | Reduce |
| Q2 2026 | 100 | $577 | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ALGS
- Vanguard Group 200.40K sh · $1.87M · Q4 2025
- Marshall Wace 246.58K sh · $1.42M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 76.25K sh · $439.94K · Q2 2026
- D. E. Shaw & Co 66.46K sh · $383.49K · Q2 2026
- UBS Group AG 59.99K sh · $346.12K · Q2 2026
- Geode Capital Management 47.17K sh · $272.32K · Q2 2026
- BlackRock Inc 30.29K sh · $174.78K · Q2 2026
- Renaissance Technologies 10.80K sh · $62.32K · Q2 2026
- Citigroup Inc 1.81K sh · $10.43K · Q2 2026
- JPMorgan Chase & Co 344 sh · $1.87K · Q2 2026
- Morgan Stanley 204 sh · $1.18K · Q2 2026